The safety and availability of blood and tissues - Progress and challenges

被引:15
作者
Goodman, JL [1 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA
关键词
D O I
10.1056/NEJMe048146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:819 / 822
页数:4
相关论文
共 15 条
[1]  
[Anonymous], INN STAGN CHALL OPP
[2]  
[Anonymous], 2004, MMWR Morb Mortal Wkly Rep, V53, P264
[3]  
*FOOD DRUG ADM CTR, 2004, GUID IND EL DET DON
[4]  
*FOOD DRUG ADM CTR, 2001, CURR GOOD TISS PRACT
[5]  
*FOOD DRUG ADM CTR, 2002, GUID IND REV PREV ME
[6]  
HILLYER CD, 2003, HEMATOL-AM SOC HEMAT, V1, P575
[7]   The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations [J].
Jackson, BR ;
Busch, MP ;
Stramer, SL ;
AuBuchon, JP .
TRANSFUSION, 2003, 43 (06) :721-729
[8]   Clostridium infections associated with musculoskeletal-tissue allografts [J].
Kainer, MA ;
Linden, JV ;
Whaley, DN ;
Holmes, HT ;
Jarvis, WR ;
Jernigan, DB ;
Archibald, LK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2564-2571
[9]   Trypanosoma cruzi in Los Angeles and Miami blood donors:: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission [J].
Leiby, DA ;
Herron, RM ;
Read, EJ ;
Lenes, BA ;
Stumpf, RJ .
TRANSFUSION, 2002, 42 (05) :549-555
[10]   Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion [J].
Llewelyn, CA ;
Hewitt, PE ;
Knight, RSG ;
Amar, K ;
Cousens, S ;
Mackenzie, J ;
Will, RG .
LANCET, 2004, 363 (9407) :417-421